Great question! When it comes to psoriasis treatments, newer biologics are showing really promising results — both in effectiveness and a lower risk of side effects compared to older options like adalimumab (Humira).
A large study found that several newer biologics had significantly fewer side effects than adalimumab:
- Show Full Answer
Great question! When it comes to psoriasis treatments, newer biologics are showing really promising results — both in effectiveness and a lower risk of side effects compared to older options like adalimumab (Humira).
A large study found that several newer biologics had significantly fewer side effects than adalimumab:
- Guselkumab — 44% lower risk of side effects
- Risankizumab — 41% lower risk
- Tildrakizumab — 40% lower risk
- Ixekizumab — 35% lower risk
- Ustekinumab — 27% lower risk On the effectiveness side, biologics in general have come a long way. Success rates have climbed from around 35–50% years ago to 85–90% today, with many people achieving completely clear skin.
The exciting part? Newer biologics seem to have broken the old "more effective = more side effects" rule. More potent options are now available without a bigger safety penalty. That said, psoriasis affects everyone differently, so what works brilliantly for one person may not be the best fit for another. It's worth having a detailed conversation with a dermatologist to weigh the options based on personal health history.
Some helpful tips when discussing treatment options:
- Ask which side effects to expect and how severe they might be
- Ask whether side effects tend to ease over time
- Discuss how to track and report any new symptoms
May 5
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
